Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preclinical Studies of Omalizumab in Chronic Rhinosinusitis With Nasal Polyposis

NCT04583501 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT04583501
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04583501 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preclinical Studies of Omalizumab in Chronic Rhinosinusitis With Nasal Polyposis
Lead sponsor
Johns Hopkins University
Phase
Phase 1
Overall status
Completed
Start date
December 15, 2020
Completion date
July 12, 2024
Enrollment
21 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic rhinosinusitis with nasal polyps, nasal polyps